NVNO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
enVVeno Medical Corp (NVNO) is not a strong buy at the moment for a beginner investor with a long-term focus. The lack of significant positive catalysts, weak financial performance, and neutral trading trends suggest that this stock is not an optimal choice for immediate investment. While technical indicators show some positive momentum, the overall fundamentals and sentiment do not align with a strong buy recommendation.
The MACD is positive and expanding, indicating upward momentum. RSI is at 79.74, which is in the neutral zone, suggesting no immediate overbought or oversold condition. The stock is trading near its resistance level (R1: 13.033), which could limit further upside in the short term.
The MACD histogram is positive and expanding, indicating potential upward momentum. The stock has a 50% chance to increase by 5.34% in the next week and 8.66% in the next month.
No significant hedge fund or insider activity. Financial performance is weak, with declining net income (-40.02% YoY) and EPS (-43.46% YoY). No recent news or congress trading data to indicate positive sentiment.
In 2025/Q4, the company's revenue remained at 0 with no growth. Net income dropped significantly to -$3,736,000 (-40.02% YoY), and EPS declined to -6.05 (-43.46% YoY). Gross margin remained at 0 with no improvement.
No analyst rating or price target changes available for evaluation.
